Literature DB >> 6853691

Enzyme-linked immunosorbent assay for antibodies against teichoic acid in patients with staphylococcal infections.

M Granström, I G Julander, S A Hedström, R Möllby.   

Abstract

A highly purified teichoic acid preparation was used in an enzyme-linked immunosorbent assay to measure the specific immunoglobulin G (IgG) and IgM response in staphylococcal disease. Antibody determination in a normal population, showing a difference of up to 20-fold in the mean IgG titers between the youngest children and adults, was used to establish age-correlated upper normal values. IgM antibodies were found to be of little diagnostic value since their response was often low or absent. Increased IgG titers were found in 24 of 27 (89%) patients with endocarditis, in 11 of 14 (79%) with complicated septicemia, and in 10 of 20 (50%) with uncomplicated septicemia with serum samples drawn between days 7 and 30 of disease. With paired samples, the numbers of patients with increased IgG titers were 17 of 17, 3 of 4, and 6 of 7, respectively, in the same patient groups. Increased IgG titers were less often demonstrated in patients with chronic osteomyelitis (7 of 22). The enzyme-linked immunosorbent assay for teichoic acid antibodies was found to be a sensitive and specific method for diagnosing staphylococcal endocarditis and septicemia. For optimal results, both the substantial age-correlated variation in normal titers and the importance of adequately spaced samples should be considered.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6853691      PMCID: PMC272709          DOI: 10.1128/jcm.17.4.640-646.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Teichoic acids in pathogenic Staphylococcus aureus.

Authors:  J G Nagel; J N Sheagren; C U Tuazon; T A Cardella
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

2.  A microplate method of enzyme-linked immunosorbent assay and its application to malaria.

Authors:  A Voller; D Bidwell; G Huldt; E Engvall
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

3.  Crossed immunoelectrophoresis.

Authors:  B Weeke
Journal:  Scand J Immunol Suppl       Date:  1973

4.  Staphylococcal antibodies and hypersensitivity to teichoic acids in man.

Authors:  R R Martin; H Daugharty; A White
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

5.  General and local antibiotic treatment of chronic osteomyelitis.

Authors:  S A Hedström
Journal:  Scand J Infect Dis       Date:  1969

6.  The specificity of fetal IgM: antibody or anti-antibody?

Authors:  C B Reimer; C M Black; D J Phillips; L C Logan; E F Hunter; B J Pender; B E McGrew
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

7.  Teichoic acid serologic diagnosis of staphylococcal endocarditis. Use of gel diffusion and counterimmunoelectrophoretic methods.

Authors:  J G Nagel; C U Tuazon; T A Cardella; J N Sheagren
Journal:  Ann Intern Med       Date:  1975-01       Impact factor: 25.391

8.  Wall teichoic acids in animal Staphylococcus aureus strains determined by precipitation.

Authors:  P Oeding
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973-06

9.  Teichoic acid antibodies in staphylococcal and nonstaphylococcal endocarditis.

Authors:  J G Crowder; A White
Journal:  Ann Intern Med       Date:  1972-07       Impact factor: 25.391

10.  Staphylococcus aureus bacteremia: relationship between formation of antibodies to teichoic acid and development of metastatic abscesses.

Authors:  C U Tuazon; J N Sheagren; M S Choa; D Marcus; J A Curtin
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

View more
  27 in total

1.  Antibody response to teichoic acid and peptidoglycan in Staphylococcus aureus osteomyelitis.

Authors:  E Jacob; L C Durham; M C Falk; T J Williams; L J Wheat
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

2.  Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population.

Authors:  Patricia Colque-Navarro; Gunnar Jacobsson; Rune Andersson; Jan-Ingmar Flock; Roland Möllby
Journal:  Clin Vaccine Immunol       Date:  2010-05-05

3.  Antibody determinations by counterimmunoelectrophoresis in the diagnosis and management of Pseudomonas aeruginosa bone and joint infections.

Authors:  D K Wagner; M T Yach; M W Rytel
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

4.  Age related variations of serum concentrations of normally occurring IgG antibodies to Clostridium perfringens.

Authors:  E Zarén; A Schwan; B Frenckner
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

5.  Staphylococcus aureus triggered reactive arthritis.

Authors:  A R Siam; M Hammoudeh
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

6.  IgG subclass distribution of antibodies against S. aureus teichoic acid and alpha-toxin in normal and immunodeficient donors.

Authors:  L Hammarström; M Granström; V Oxelius; M A Persson; C I Smith
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

7.  Antistaphylococcal antibodies in cystic fibrosis.

Authors:  B Strandvik; A Hollsing; R Möllby; M Granström
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

8.  Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.

Authors:  M B Marques; D L Kasper; A Shroff; F Michon; H J Jennings; M R Wessels
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Detection of antibody to staphylococcal lipoteichoic acid with a microenzyme-linked immunosorbent assay.

Authors:  M M Carruthers; K E Jenkins; W J Kabat; T Buranosky
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

10.  Comparison of a new enzyme-linked immunosorbent assay method with counterimmunoelectrophoresis for detection of teichoic acid antibodies in sera from patients with Staphylococcus aureus infections.

Authors:  C Herzog; H C Wood; I Noel; J C Booth
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.